resveratrol has been researched along with Carcinoma, Ehrlich Tumor in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ančić, D; Odeh, D; Oršolić, N; Pepić, I; Ramić, S; Tomašević, M | 1 |
| Bekhit, AA; El-Far, SW; Elzoghby, AO; Helmy, MW; Hussein, AA; Khattab, SN | 1 |
| Mishra, S; Rai, G; Shukla, Y; Suman, S | 1 |
| Al-Gayyar, MM; Darweish, MM; El-Mesery, ME; El-Mowafy, AM; Salem, HA | 1 |
| El-Awady, el-S; El-Azab, M; Hishe, H; Moustafa, Y | 1 |
5 other study(ies) available for resveratrol and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Resveratrol and its nanocrystals: A promising approach for cancer therapy?
Topics: Abdominal Cavity; Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Carcinoma, Ehrlich Tumor; Cell Line; Cell Proliferation; Humans; Inflammation; Injections, Intraperitoneal; Male; Mice; Nanoparticles; Particle Size; Peritoneum; Regional Blood Flow; Resveratrol; Xenograft Model Antitumor Assays | 2022 |
Phytosomal bilayer-enveloped casein micelles for codelivery of monascus yellow pigments and resveratrol to breast cancer.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Caseins; Cell Survival; Drug Carriers; Drug Therapy, Combination; Female; Flavins; Heterocyclic Compounds, 3-Ring; Humans; Hydrophobic and Hydrophilic Interactions; MCF-7 Cells; Mice, Inbred BALB C; Micelles; Monascus; Nanoparticles; Particle Size; Rats; Resveratrol | 2018 |
Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: A mechanistic insight.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Carcinoma, Ehrlich Tumor; Cell Cycle; Cell Line, Tumor; Doxorubicin; Female; Humans; Male; Mice; NF-kappa B; Resveratrol; Stilbenes | 2016 |
Prominent chemopreventive and chemoenhancing effects for resveratrol: unraveling molecular targets and the role of C-reactive protein.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; Carcinoma, Ehrlich Tumor; Cisplatin; Female; Leukocyte Count; Malondialdehyde; Mice; Resveratrol; Stilbenes; Tumor Necrosis Factor-alpha | 2010 |
Anti-angiogenic effect of resveratrol or curcumin in Ehrlich ascites carcinoma-bearing mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Curcumin; Mice; Neoplasms, Experimental; Neovascularization, Pathologic; Resveratrol; Stilbenes; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2011 |